Usefulness of the plasma branched-chain amino acid/aromatic amino acid ratio for predicting future cardiac events in patients with heart failure.


Journal

Journal of cardiology
ISSN: 1876-4738
Titre abrégé: J Cardiol
Pays: Netherlands
ID NLM: 8804703

Informations de publication

Date de publication:
06 2020
Historique:
received: 25 10 2019
revised: 14 12 2019
accepted: 29 12 2019
pubmed: 1 2 2020
medline: 22 5 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

Heart failure (HF) is a hypercatabolic state that promotes branched-chain amino acid (BCAA) catabolic activity in the heart and skeletal muscle and reduces protein synthesis in the liver. Consequently, plasma free aromatic amino acids (AAAs) are increased. We investigated the prognostic value of the BCAA/AAA ratio (Fischer's ratio, FR) in patients with HF. We enrolled 157 consecutive patients hospitalized for worsening HF (81 men, 76 women; mean ± SD age 75 ± 14 years). Plasma BCAA levels (i.e. total leucine, isoleucine, valine) and AAA levels (i.e. total tyrosine, phenylalanine) were measured at a time when the patients were stabilized (at discharge). FR was calculated as the combined plasma BCAA levels divided by the AAA level. Cardiac events were defined as a composite of cardiac death and hospitalization for worsening HF. The patients were divided into two groups based on the median FR (high-FR group: FR ≥ 3.1, n = 78; low-FR group: FR < 3.1, n = 79). Compared with the high-FR group, low-FR patients were older, had more prior hospitalizations for HF, lower albumin and cholinesterase levels, and lower geriatric nutritional risk index (GNRI). Altogether, 46 cardiac events occurred during the follow-up period (221 ± 135 days), including 14 cardiac deaths and 32 hospitalizations for worsening HF. In a Kaplan-Meier survival analysis, the low-FR group had more cardiac events than the high-FR group (log-rank, p < 0.001). The best cut-off value of FR was determined as 2.9 in the receiver operating characteristic curve for cardiac events. A multivariate Cox proportional hazards regression analysis showed that being in the low-FR group was an independent determinant of cardiac events from parameters of liver function tests and GNRI. FR might be useful for predicting future cardiac events in patients with HF, reflecting nutritional status which cannot be assessed by liver function tests and GNRI.

Sections du résumé

BACKGROUND
Heart failure (HF) is a hypercatabolic state that promotes branched-chain amino acid (BCAA) catabolic activity in the heart and skeletal muscle and reduces protein synthesis in the liver. Consequently, plasma free aromatic amino acids (AAAs) are increased. We investigated the prognostic value of the BCAA/AAA ratio (Fischer's ratio, FR) in patients with HF.
METHODS
We enrolled 157 consecutive patients hospitalized for worsening HF (81 men, 76 women; mean ± SD age 75 ± 14 years). Plasma BCAA levels (i.e. total leucine, isoleucine, valine) and AAA levels (i.e. total tyrosine, phenylalanine) were measured at a time when the patients were stabilized (at discharge). FR was calculated as the combined plasma BCAA levels divided by the AAA level. Cardiac events were defined as a composite of cardiac death and hospitalization for worsening HF.
RESULTS
The patients were divided into two groups based on the median FR (high-FR group: FR ≥ 3.1, n = 78; low-FR group: FR < 3.1, n = 79). Compared with the high-FR group, low-FR patients were older, had more prior hospitalizations for HF, lower albumin and cholinesterase levels, and lower geriatric nutritional risk index (GNRI). Altogether, 46 cardiac events occurred during the follow-up period (221 ± 135 days), including 14 cardiac deaths and 32 hospitalizations for worsening HF. In a Kaplan-Meier survival analysis, the low-FR group had more cardiac events than the high-FR group (log-rank, p < 0.001). The best cut-off value of FR was determined as 2.9 in the receiver operating characteristic curve for cardiac events. A multivariate Cox proportional hazards regression analysis showed that being in the low-FR group was an independent determinant of cardiac events from parameters of liver function tests and GNRI.
CONCLUSIONS
FR might be useful for predicting future cardiac events in patients with HF, reflecting nutritional status which cannot be assessed by liver function tests and GNRI.

Identifiants

pubmed: 32001073
pii: S0914-5087(20)30017-4
doi: 10.1016/j.jjcc.2019.12.016
pii:
doi:

Substances chimiques

Amino Acids, Aromatic 0
Amino Acids, Branched-Chain 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

689-696

Informations de copyright

Copyright © 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Auteurs

Hiroaki Hiraiwa (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Takahiro Okumura (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: takaoku@med.nagoya-u.ac.jp.

Toru Kondo (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toshiaki Kato (T)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Shingo Kazama (S)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Toshikazu Ishihara (T)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Etsuo Iwata (E)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masafumi Shimojo (M)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Sayano Kondo (S)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Soichiro Aoki (S)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Yasunori Kanzaki (Y)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Daisuke Tanimura (D)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Hiroaki Sano (H)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Yoshifumi Awaji (Y)

Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan.

Sumio Yamada (S)

Department of Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toyoaki Murohara (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH